Table 2.
Antibiogram study of Staphylococcus aureus isolates in the current study.
| Antibacterial Agents (μg/disc) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isolates (n = 48) |
Diameter of Zone of Inhibition (mm) | AMX (30) |
C (30) |
NX (10) |
TE (30) |
GEN (10) |
B (10) |
AZM (30) |
E (15) |
NV (30) |
MET (5) |
VA (30) |
LE (5) |
CIP (5) |
CH (25) |
NA (30) |
| Staphylococcus aureus | S | 15 mm | 19 mm | 21 mm | 23 mm |
26 mm |
29 mm |
|||||||||
| I | 20 mm |
11 mm |
17 mm |
24 mm |
||||||||||||
| R | 0 | 0 | 0 | 0 | 0 | |||||||||||
GEN: gentamicin; AMX: amoxicillin; C: chloramphenicol; CIP: ciprofloxacin; AZM: azithromycin; E: erythromycin; VA: vancomycin; NX: norfloxacin; TE: tetracycline; B: bacitracin; NV: novobiocin; MET: methicillin; LE: levofloxacin; CH: cephradine; NA: nalidixic acid; 0: no zone of inhibition; S: sensitive; I: intermediate; R: resistant.